Peripheral Arterial Disease (PAD) Therapeutics Global Strategic Research Report 2024 Dublin, March 01, 2024 (GLOBE NEWSWIRE) -- The "Peripheral Arterial Disease (PAD) Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global...

ZyVersa Therapeutics Announces a Publication in Journal of the American Heart Association Linking NLRP3 Inflammasomes with Calcification in Arteries of Patients with Peripheral Arterial Disease (PAD) PAD, characterized by vascular inflammation and associated calcification, affects 8.5 million people in the United States and contributes to more than 50,000 limb amputations annually, yet there are...

Peripheral Vascular Devices Market estimated to surge ahead at a CAGR of 6.6% by the end of 2032 – Persistence Market Research New York, Sept. 20, 2022 (GLOBE NEWSWIRE) -- The global peripheral vascular devices market was worth US$ 4.5 Bn in 2021 and t is expected to expand at a high CAGR of 6.6% over the forecast period...

Hyperlipidemia Drugs Market Size, Share, Qualitative Analysis and Industry Growth Factors and is growing at a CAGR of 2.2% by 2029 Luton, Bedfordshire, United Kingdom, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Exactitude Consultancy, the market research and consulting wing of Ameliorate Digital Consultancy Private Limited has completed...

Holy Name Medical Center First in the Northeast to Offer Magellan(TM) Robotic System TEANECK, N.J., Nov. 19, 2015 (GLOBE NEWSWIRE) -- Physicians at Holy Name Medical Center are the first in the Northeast to use the Magellan™ Robotic System, which enables them to perform complex,...